Mouse Monoclonal LAMA3 antibody. Suitable for IHC-Fr and reacts with Human samples. Cited in 22 publications.
View Alternative Names
LAMNA, LAMA3, Laminin subunit alpha-3, Epiligrin 170 kDa subunit, Epiligrin subunit alpha, Kalinin subunit alpha, Laminin-5 subunit alpha, Laminin-6 subunit alpha, Laminin-7 subunit alpha, Nicein subunit alpha, E170
- IHC-Fr
AbReview38484****
Immunohistochemistry (Frozen sections) - Anti-Laminin 5 antibody [P3H9-2] (AB78286)
ab78286 staining Laminin 5 in Human cultured skin (NHEK, NB1RGB) tissue sections by Immunohistochemistry (IHC-Fr - frozen sections). Tissue was fixed with formaldehyde, permeabilized with 0.1% Triton X-100 and blocked with 10% Blocking One® for 1 hour at 25°C. Samples were incubated with primary antibody (1/500 in 10% Blocking One® in PBS) for 1 hour at 25°C. An Alexa Fluor® 555-conjugated Rabbit anti-mouse IgG polyclonal (1/200) was used as the secondary antibody.
This image is courtesy of an anonymous Abreview
- IHC-Fr
Lab
Immunohistochemistry (Frozen sections) - Anti-Laminin 5 antibody [P3H9-2] (AB78286)
IHC image of Laminin 5 staining in a section of frozen normal human colon*, performed on a Leica Bond™ system using the standard protocol F. No antigen retrieval step was performed prior to staining. The section was incubated with ab78286, 1 μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre
- IHC-Fr
Unknown
Immunohistochemistry (Frozen sections) - Anti-Laminin 5 antibody [P3H9-2] (AB78286)
IHC image of Laminin 5 staining in a section of frozen normal human skin*, performed on a Leica Bond™ system using the standard protocol F. No antigen retrieval step was performed prior to staining. The section was incubated with ab78286, 1 μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre.
Reactivity data
Product details
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Laminin 5 forms part of the integrin complexes that modulate interactions between cells and the extracellular matrix. It provides critical structural support and influences cell behavior within the tissue microenvironment. Laminin 5 participates in the anchoring of keratinocytes to the underlying basement membrane which is essential for skin integrity and maintenance. Its interaction with laminin receptors on the cell surface strengthens the cellular attachment impacting the overall integrity and mechanical resistance of tissues.
Pathways
Laminin 5 is integral to the hemidesmosome assembly pathway and the MAPK/ERK signaling pathway. These pathways involve its interactions with integrins such as alpha-6 beta-4 and other proteins like dystroglycan. Laminin molecules including laminin 5 influence the downstream signaling of MAPK/ERK which governs processes like cellular proliferation and differentiation. The linkage with integrin-mediated signaling pathways allows laminin 5 to participate actively in cell adhesion mechanisms and responses to extracellular matrix changes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (22)
Recent publications for all applications. Explore the full list and refine your search
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) 29:e13350 PubMed37357659
2023
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 24:e56212 PubMed37154297
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in molecular neuroscience 15:926567 PubMed36452406
2022
Applications
Unspecified application
Species
Unspecified reactive species
Advanced materials (Deerfield Beach, Fla.) 34:e2106780 PubMed34933407
2022
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 12:317 PubMed35013350
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cells 10: PubMed34201301
2021
Applications
Unspecified application
Species
Unspecified reactive species
Stem cells (Dayton, Ohio) 39:897-903 PubMed33609408
2021
Applications
Unspecified application
Species
Unspecified reactive species
Histochemistry and cell biology 155:529-545 PubMed33404706
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in bioengineering and biotechnology 8:579896 PubMed33344431
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cells 9: PubMed32824646
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com